A prospective multicentre study on the safety of long‐term intensive plasmapheresis in donors (SIPLA)
Authors:
- 5 July 2006
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 91 (2) , 162-173
Abstract
Background and Objectives The safety of chronic intensive donor plasmapheresis has not been determined in large prospective studies examining dropout rates, dropout reasons and predictors of withdrawals.Materials and Methods Twenty‐one plasma centres recruited 3783 donors who were switched from a moderate to an intensive plasmapheresis programme and observed over a 3‐year period. Individuals weighing < 70 kg and ≥ 70 kg donated 750 ml and 850 ml of plasma per session, respectively. The maximum of annual donations was limited to 60. Total serum protein (TSP) and haemoglobin (Hb) or haematocrit (Hct) were determined at each donation, and immunoglobulin G (IgG) at every fifth donation. Dropout rates, dropout reasons and potential predictors of withdrawal were analysed.Results Dropouts were predominantly due to socioeconomic (49·2% of all donors) or medical reasons not related to plasma donations (10·4% of all donors). Sixteen per cent of donors dropped out when IgG, TSP or Hb levels fell below threshold values. Severe clinical adverse events related to plasmapheresis were observed in five subjects. The incidence in severe cardiovascular diseases was lower in donors than in the general population. The risk factors that led to dropping out as a result of low IgG, TSP or Hb levels included younger age, female gender, low initial IgG levels and a high donation frequency. Neither body weight nor the amounts of plasma donated per kilogram of body weight per session were associated with ceasing due to medical reasons, whether related or unrelated to plasma donations. Females and males within the respective lowest body weight category were not at higher risk of dropping out.Conclusion Long‐term intensive donor plasmapheresis under conditions investigated in this study is safe. All donors weighing ≥ 70 kg are safely able to donate 850 ml of plasma in each session up to 60 times per year, provided that they are carefully monitored.Keywords
This publication has 17 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- A prospective trial on the safety of long‐term intensive plasmapheresis in donorsVox Sanguinis, 2005
- Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiologyThe American Journal of Medicine, 2004
- The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markersVox Sanguinis, 2004
- Gender differences in health-related quality of life.Health Psychology, 1991
- Intensive Plasmapheresis as a Risk Factor for Arteriosclerotic Cardiovascular Disease?Vox Sanguinis, 1977
- Volume Limitations of PlasmapheresisVox Sanguinis, 1977
- Short‐Term and Long‐Term Effects of Plasmapheresis on Serum Proteins and ImmunoglobulinsTransfusion, 1975
- The Effect of Prolonged Plasmapheresis on Immunoglobulins, other Serum Proteins, Delayed Hypersensitivity and Phytohemagglutinin-Induced Lymphocyte TransformationInternational Archives of Allergy and Immunology, 1971
- Safety and Long‐term Effects of PlasmapheresisTransfusion, 1970